BlackRock Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$243M Sell
1,987,406
-44,066
-2% -$5.39M 0.12% 216
2016
Q3
$249M Sell
2,031,472
-3,823
-0.2% -$492K 0.13% 194
2016
Q2
$238M Sell
2,035,295
-13,527
-0.7% -$1.92M 0.12% 193
2016
Q1
$285M Sell
2,048,822
-381,110
-16% -$56M 0.15% 153
2015
Q4
$464M Sell
2,429,932
-17,479
-0.7% -$3.05M 0.26% 80
2015
Q3
$383M Buy
2,447,411
+105,757
+5% +$19.3M 0.23% 102
2015
Q2
$423M Buy
2,341,654
+235,956
+11% +$40.7M 0.23% 98
2015
Q1
$365M Sell
2,105,698
-24,768
-1% -$4.48M 0.2% 112
2014
Q4
$394M Buy
2,130,466
+147,089
+7% +$27.3M 0.21% 106
2014
Q3
$329M Buy
1,983,377
+23,059
+1% +$3.79M 0.19% 113
2014
Q2
$306M Buy
1,960,318
+115,407
+6% +$18.2M 0.18% 130
2014
Q1
$281M Buy
1,844,911
+358,961
+24% +$57.1M 0.18% 133
2013
Q4
$197M Buy
1,485,950
+59,271
+4% +$7.11M 0.13% 178
2013
Q3
$166M Sell
1,426,679
-5,074
-0.4% -$557K 0.11% 205
2013
Q2
$132M Buy
+1,431,753
New +$138M 0.1% 235

Other funds holding ALXN